Giancaspro v. Novartis Pharmaceuticals Corporation
Plaintiff: Jeffrey Giancaspro
Defendant: Novartis Pharmaceuticals Corporation
Case Number: 6:2021cv01312
Filed: August 13, 2021
Court: US District Court for the Middle District of Florida
Presiding Judge: David A Baker
Referring Judge: Roy B Dalton
2 Judge: Gregory J Kelly
Nature of Suit: Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Cause of Action: 28 U.S.C. § 1332
Jury Demanded By: Both
Docket Report

This docket was last retrieved on September 24, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 24, 2021 Filing 40 NOTICE of Appearance by Melanie H. Muhlstock on behalf of Jeffrey Giancaspro (Muhlstock, Melanie)
September 24, 2021 Filing 39 NOTICE of Appearance by Harrison Macy Biggs on behalf of Jeffrey Giancaspro (Biggs, Harrison)
September 14, 2021 Filing 38 BRIEF on Case Status in Giancaspro by Novartis Pharmaceuticals Corporation. (Johnston, Robert) Modified text on 9/15/2021 (TNP).
September 14, 2021 Filing 37 Member Case BRIEF by Jeffrey Giancaspro. (Silverman, Raymond) Modified text on 9/15/2021 (TNP).
September 14, 2021 Filing 36 NOTICE of Appearance by Raymond C. Silverman on behalf of Jeffrey Giancaspro (Silverman, Raymond)
September 14, 2021 Filing 35 NOTICE of Appearance by Christopher Carl Oxx on behalf of Jeffrey Giancaspro (Oxx, Christopher)
September 14, 2021 Filing 34 NOTICE of Appearance by Joe Gregory Hollingsworth on behalf of Novartis Pharmaceuticals Corporation (Hollingsworth, Joe)
September 13, 2021 Filing 33 NOTICE of Appearance by Robert E. Johnston on behalf of Novartis Pharmaceuticals Corporation (Johnston, Robert)
September 13, 2021 Filing 32 NOTICE of Appearance by Grant Hollingsworth on behalf of Novartis Pharmaceuticals Corporation (Hollingsworth, Grant)
September 13, 2021 Filing 31 NOTICE of Appearance by Andrew L. Reissaus on behalf of Novartis Pharmaceuticals Corporation (Reissaus, Andrew)
August 31, 2021 Opinion or Order Filing 30 PRETRIAL ORDER NO. 1. Status Conference set for 9/28/2021 at 10:00 AM in Orlando Courtroom 4 A before Judge Roy B. Dalton, Jr. All motions pending as of the date of this Order are DENIED WITHOUT PREJUDICE. Parties seeking relief should renew any motions by refiling them in the individual member cases or in the lead case as appropriate. Signed by Judge Roy B. Dalton, Jr. on 8/31/2021. Associated Cases: 6:21-md-03006-RBD-DAB et al.(BIA) (Additional attachment(s) added on 9/1/2021: #1 Exhibit A) (BIA).
August 17, 2021 Filing 29 Case Reassigned to Magistrate Judge David A Baker per Order at Doc. 2 in case 6:21-md-3006-RBD-DAB. New case number: 6:21-cv-01312-RBD-DAB. Magistrate Judge Gregory J. Kelly no longer assigned to the case. (ALL)
August 13, 2021 Filing 28 MULTIDISTRICT LITIGATION member case. Master MDL case number: 3006 Receipt of original record from the Middle District of Florida, case number: 3:20-cv-00346-BJD-MCR. Assigned MDFL case number: 6:21-cv-01312-RBD-GJK. (ALL)
August 13, 2021 Filing 27 Case transferred in from District of Florida Middle; Case Number 3:20-cv-00346. File received electronically
August 12, 2021 Filing 26 MULTIDISTRICT LITIGATION panel order transferring case to: Orlando Division. Assigned case number: 6:21-md-3006-RBD-GJK. MDL case number: 3006 (SJW) [Transferred from flmd on 8/13/2021.]
July 13, 2021 Opinion or Order Filing 25 ENDORSED ORDER: #23 Plaintiff's Motion to Stay is DENIED. Signed by Judge Brian J. Davis on 7/12/2021. (AMP) [Transferred from flmd on 8/13/2021.]
July 6, 2021 Filing 24 MEMORANDUM in opposition re #23 Motion to Stay filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1)(Thomas, Michael) [Transferred from flmd on 8/13/2021.]
June 22, 2021 Filing 23 MOTION to Stay by Jeffrey Giancaspro. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Albites, Francisco) [Transferred from flmd on 8/13/2021.]
May 21, 2021 Opinion or Order Filing 22 ENDORSED ORDER granting #21 Joint Motion to Extend Mediation Deadline. The mediation deadline is extended to November 22, 2021. All other terms and deadlines in #14 Case Management and Scheduling Order shall remain intact. Signed by Magistrate Judge Monte C. Richardson on 5/21/2021. (DLC) [Transferred from flmd on 8/13/2021.]
May 20, 2021 Filing 21 Joint MOTION to Modify #14 Case Management / FLSA / ADA / Social Security / Scheduling Order TO EXTEND MEDIATION DEADLINE by Jeffrey Giancaspro. (Albites, Francisco) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.]
August 6, 2020 Opinion or Order Filing 20 ORDER appointing Dominic M. Caparello, Esq. as mediator in this action. Signed by Judge Brian J. Davis on 8/6/2020. (CKS) [Transferred from flmd on 8/13/2021.]
August 4, 2020 Filing 19 NOTICE OF SELECTION of Dominic Caparello as mediator by Novartis Pharmaceuticals Corporation. (Thomas, Michael) [Transferred from flmd on 8/13/2021.]
July 9, 2020 Filing 18 CERTIFICATE of interested persons and corporate disclosure statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) [Transferred from flmd on 8/13/2021.]
July 9, 2020 Filing 17 CERTIFICATE of interested persons and corporate disclosure statement re #14 Case management and scheduling order by Jeffrey Giancaspro. (Albites, Francisco) [Transferred from flmd on 8/13/2021.]
June 23, 2020 Filing 16 NOTICE of compliance re 12 Order on Motion to Appear Pro Hac Vice by Jeffrey Giancaspro (Albites, Francisco) [Transferred from flmd on 8/13/2021.]
June 16, 2020 Filing 15 CASE REFERRED to Mediation. (AEJ) [Transferred from flmd on 8/13/2021.]
June 16, 2020 Opinion or Order Filing 14 CASE MANAGEMENT AND SCHEDULING ORDER: Mediator selection due by 8/4/2020; Conduct mediation hearing by 5/21/2021; Discovery due by 4/15/2022; Dispositive motions due by 4/15/2022; Pretrial statement due by 9/14/2022; Final Pretrial Conference set for 9/21/2022 at 10:00 AM in Jacksonville Courtroom 12 C before Judge Brian J. Davis; Jury Trial set for trial term commencing on 10/3/2022 at 9:00 AM in Jacksonville Courtroom 12 C before Judge Brian J. Davis. Signed by Judge Brian J. Davis on 6/16/2020. (Attachments: #1 Mediation Report Form, #2 Docket Sheets)(AMP) [Transferred from flmd on 8/13/2021.]
June 8, 2020 Filing 13 CASE MANAGEMENT REPORT. (Attachments: #1 Exhibit Confidentiality Agreement, #2 Exhibit Proposed Order)(Albites, Francisco) [Transferred from flmd on 8/13/2021.]
June 5, 2020 Opinion or Order Filing 12 ENDORSED ORDER granting #8 Motion to Appear Pro Hac Vice; granting #9 Motion to Appear Pro Hac Vice; granting #10 Motion to Appear Pro Hac Vice; granting #11 Motion to Appear Pro Hac Vice. If Attorneys Silverman, Reissaus, McMinn, and Johnston have not already done so, they shall immediately register for a login and password for electronic filing at the Court's website at www.flmd.uscourts.gov. Signed by Magistrate Judge Monte C. Richardson on 6/5/2020. (MM) [Transferred from flmd on 8/13/2021.]
June 4, 2020 Filing 11 MOTION for Robert E. Johnston to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16891696 for $150 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Affidavit Special Admission Certificate)(Thomas, Michael) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.]
June 4, 2020 Filing 10 MOTION for Donald R. McMinn to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16891677 for $150 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Affidavit Special Admission Certificate)(Thomas, Michael) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.]
June 4, 2020 Filing 9 MOTION for Andrew L. Reissaus to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16891611 for $150 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Affidavit Special Admission Certificate)(Thomas, Michael) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.]
June 3, 2020 Filing 8 MOTION for Raymond C. Silverman to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16886928 for $150 by Jeffrey Giancaspro. (Albites, Francisco) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.]
May 22, 2020 Filing 7 CERTIFICATE of interested persons and corporate disclosure statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) [Transferred from flmd on 8/13/2021.]
April 29, 2020 Filing 6 CORPORATE Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) [Transferred from flmd on 8/13/2021.]
April 29, 2020 Filing 5 ANSWER and affirmative defenses to #1 Complaint with Jury Demand by Novartis Pharmaceuticals Corporation.(Thomas, Michael) [Transferred from flmd on 8/13/2021.]
April 15, 2020 Filing 4 NOTICE of designation under Local Rule 3.05 - track 2. Signed by Deputy Clerk on 4/15/2020. (Attachments: #1 Case Management Report Form, #2 Consent Letter and Form)(CKS) [Transferred from flmd on 8/13/2021.]
April 7, 2020 Filing 3 SUMMONS issued as to Novartis Pharmaceuticals Corporation. (AEJ) [Transferred from flmd on 8/13/2021.]
April 6, 2020 Filing 2 NEW CASE ASSIGNED to Judge Brian J. Davis and Magistrate Judge Monte C. Richardson. New case number: 3:20-cv-346-J-39MCR. (SJB) [Transferred from flmd on 8/13/2021.]
April 6, 2020 Filing 1 COMPLAINT against Novartis Pharmaceuticals Corporation with Jury Demand (Filing fee $ 400 receipt number 113A-16670425) filed by Jeffrey Giancaspro. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons)(Albites, Francisco) [Transferred from flmd on 8/13/2021.]

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System

Search for this case: Giancaspro v. Novartis Pharmaceuticals Corporation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Jeffrey Giancaspro
Represented By: Raymond C. Silverman
Represented By: Francisco Antonio Albites
Represented By: Christopher Carl Oxx
Represented By: Harrison Macy Biggs
Represented By: Melanie H. Muhlstock
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novartis Pharmaceuticals Corporation
Represented By: Jacqueline A.R. Root
Represented By: Kathryn L. Hood
Represented By: Michael J. Thomas
Represented By: Andrew L. Reissaus
Represented By: Donald R. McMinn
Represented By: Robert E. Johnston
Represented By: Joe Gregory Hollingsworth
Represented By: Grant Hollingsworth
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?